Generated Narrative: ValueSet edqm-isi

• Include these codes as defined in http://standardterms.edqm.eu version ⏿5 February 2025

  Code	Display	Definition
  0021	Auricular	Relating to the ear as the intended site of administration, usually where the pharmaceutical product is intended for action in the auditory canal (external auditory meatus).
  0022	Cutaneous	Relating to the skin or its appendages (e.g. hair, nails) as the intended site of administration, where the pharmaceutical product is intended for a local action on or within the skin or the appendage.
  0023	Dental	Relating to the teeth as the intended site of administration, including where the pharmaceutical product is intended for action on the surface of the tooth, inside the tooth, or around the tooth.
  0024	Environmental	Relating to the surroundings in which the target of the pharmaceutical product is found, as the intended site of administration, e.g. an enclosed volume of water or air; usually the product disperses in the area and is subsequently taken up by the subject.
  0025	Extracorporeal	Relating to a body substance or tissue as the intended site of administration, after being removed from the body in order to be treated with the pharmaceutical product and then subsequently returned to the body.
  0027	Intrauterine	Relating to the cavity of the uterus as the intended site of administration.
  0028	Intravesical	Relating to the urinary bladder as the intended site of administration.
  0029	Nasal	Relating to the nose as the intended site of administration, including where the pharmaceutical product is intended for local action in the nasal cavity or for systemic action after absorption through the mucous membrane; the lower respiratory tract is excluded.
  0030	Ocular	Relating to the eye as the intended site of administration, including where the pharmaceutical product is intended for action on the surface of the eye or conjunctiva, around the eye, or within the eye.
  0031	Oral	Relating to the mouth as the intended site of administration, but where the pharmaceutical product is administered with the intention of passing into the stomach via the oesophagus; the mucosa of the mouth itself is not the intended site of action (see oromucosal).
  0032	Oromucosal	Relating to the mouth as the intended site of administration, where the pharmaceutical product is intended for local action on the mucosa of the mouth. Buccal and sublingual sites are excluded.
  0033	Parenteral	Relating to the internal body as the intended site of administration, other than the natural openings and cavities such as the gastrointestinal tract, auditory canal, nasal cavity, lungs, etc.; the pharmaceutical product is usually administered by breaking the skin, such as by injection, infusion, and implantation.
  0034	Pulmonary	Relating to the lungs as the intended site of administration, where the pharmaceutical product is administered, usually by inhalation, for local action in the lower respiratory tract or for systemic action after absorption via the lower respiratory tract.
  0035	Rectal	Relating to the rectum as the intended site of administration, where the pharmaceutical product is administered via the anal canal, for local action in the rectum or for systemic action after absorption via the rectum.
  0036	Vaginal	Relating to the vagina as the intended site of administration, where the pharmaceutical product is administered via the vaginal opening, usually for local action in the vagina but sometimes for systemic action after absorption via the vagina.
  0037	Unknown/Miscellaneous	Relating to various unspecified parts of the body as the intended site of administration, or where the intended site of administration is unknown or not specified.
  0105	Endocervical	Relating to the cervix uteri as the intended site of administration.
  0106	Gastric	Relating to the stomach as the intended site of administration, where direct administration is achieved using an appropriate device.
  0107	Gastroenteral	Relating to the stomach or duodenum as the intended site of administration, where direct administration is achieved using an appropriate device.
  0108	Intestinal	Relating to the intestines (duodenum, jejunem, ileum, colon) as the intended site of administration, where direct administration is achieved using an appropriate device.
  0109	Intraperitoneal	Relating to the peritoneal cavity as the intended site of administration.
  0116	Transdermal	Relating to the skin or its appendages (e.g. hair, nails) as the intended site of administration, where the pharmaceutical product is intended for a systemic action after passing through the skin.
  0117	Buccal	Relating to the buccal cavity of the mouth (the pouch located between the cheek and the gum) as the intended site of administration, where the pharmaceutical product is intended for a systemic action after passing through the buccal mucosa.
  0118	Sublingual	Relating to the sublingual area of the mouth (under the tongue) as the intended site of administration, where the pharmaceutical product is intended for a systemic action after passing through the sublingual mucosa.
  0119	Urethral	Relating to the urethra (the urogenital canal, connecting the bladder to the outside of the body) as the intended site of administration.